- Our LinkedIn Page
- Our Twitter Feed
- Our Facebook Page
- Newsletter Subscribe to our e-newsletter. Current Issue
- Our Flickr Feed
- Our YouTube Feed
Tags
economy NIH healthcare regulation FDA approval biotechnology health Global Health Research and Development drug development Food and Drug Administration Health Care National Institutes of Health STEM Education BIO Investor Forum vaccines public policy BIOTECH biosimilars FDAAuthors
- Abigail Hirsch
- Alan Eisenberg
- BIOtechNOW Editor
- Bruce Dale
- Celia Economides
- Colleen Lerro
- David Thomas, CFA
- George Goodno
- George MacDougall
- Jason Corum
- Jeff Joseph
- Jim Greenwood
- Karen Batra
- Kelly Cappio
- Lila Feisee
- Matt Carr
- Nathan Schock
- Paul Winters
- Paulina Ibarra
- Robbi Lycett
- Roy Zwahlen
- Sarah Sneeringer
- Sondra Behan
- Stephanie Fischer
- Stephen Marmaras
- Tracy Cooley
Health
Category Archives: Health
Latest From Health
Biologics & Biosimilars: What is the Science Telling Us?
Panelists from the varied backgrounds of academia, business and regulation agreed on the highest scientific standards of biosimilar regulation. Each panelist emphasized the need for the most stringent of standards in order to ensure patient safety and efficacy within the emerging biosimilars market. As Brian Liang, Executive Director of the Institute of Health Law Studies at California Western School of Law, summed it up, “the need in biosimilars is to focus on science, not cost. These are Read More >
Managing Biotech Technological Innovation in a New Era
Written by Kelly Cappio, BIO. This session focused on technological innovations and how they can be used to prevent, identify, or respond to new natural or man-made threats. As stated by Dr. Alan Rudolph, “We face a very dynamic threat space.” Dr. Rudolph, Director of the Chemical and Biological Technologies Directorate at the Defense Threat Reduction Agency, discussed the strategic thrust of the agency and its recent focus on new diagnostic technologies, such as MIMIC, Read More >
Podcast: 2011 Dr. Paul Janssen Award winner Dr. Napoleone Ferrara
Dr. Napoleone Ferrara, a Genentech Fellow, was named the 2011 winner of The Dr. Paul Janssen Award for Biomedical Research. Dr. Ferrrara was recognized for his research on angiogenesis, the process of new blood vessel formation, and the isolation and cloning of vascular endothelial growth factor (VEGF), a major regulator of angiogenesis in physiology and disease. Download the podcast
Current Challenges in Payment Reform
By Alyson Pusey, BIO. The Affordable Care Act created several demonstration projects to test innovative care delivery systems that increase quality of care while decreasing costs. Speaking as a panelist was Jonathan Blum, Deputy Administrator and Director of the Center for Medicare at CMS, who discussed how the agency is thinking about payment reform. Evidenced by the recent proposed rule on accountable care organizations (ACOs), the agency is looking to providers and the health care Read More >
Biotechnology Innovation: Impact of Health Reform and Deficit Control
By Alyson Pusey, BIO. With many governors around the country facing budget shortfalls, “the action is all in the states” in terms of health care cuts and cost-savings solutions, according to panelists participating. The current fiscal environment has forced cash-strapped states to look at their Medicaid programs for ways to rein in costs, and according to panelists, state lawmakers will continue to do so for the foreseeable future. For example, as a result of the Read More >
